Baseline FDG Uptake And Peripheral Lymphocyte-Monocyte Ratio For Predicting Chemoradiotherapy Response In Patients With Esophageal Squamous Cell Carcinoma

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1 ):7–30. doi:10.3322/caac.2133226742998
   PubMed Web of Science ®Google Scholar
• PC E, RJ M. Esophageal cancer. N Engl J Med. 2003;349(23 ):2241–2252. doi:10.1056/NEJMra03501014657432
   PubMed Web of Science ®Google Scholar
• Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of locally advanced esophageal cancer long-term follow-up of a prospective randomized trial (RTOG 85-01).Radiation Therapy Oncology Group. JAMA. 1999;281(17 ):1623–1627. doi:10.1001/jama.281.17.162310235156
   PubMed Web of Science ®Google Scholar
• Pöttgen C, Stuschke M. Radiotherapy versus surgery within multimodality protocols for esophageal cancer - A meta-analysis of the randomized trials. Cancer Treat Rev. 2012;38(6 ):599–604. doi:10.1016/j.ctrv.2011.10.00522116018
   PubMed Web of Science ®Google Scholar
• Bockorny B, Pectasides E. The emerging role of immunotherapy in gastric and esophageal adenocarcinoma. Future Oncol. 2016;12(15 ):1833–1846. doi:10.2217/fon-2016-010327166503
   PubMed Web of Science ®Google Scholar
• Yoshimoto Y, Kono K, Suzuki Y. anti-tumor immune responses induced by radiotherapy: a review. Fukushima J Med Sci. 2015;61(1 ):13–22. doi:10.5387/fms.2015-626135666
   PubMedGoogle Scholar
• Hsu PP, Sabatini DM. Cancer cell metabolism: warburg and beyond. Cell. 2008;134(5 ):703–707. doi:10.1016/j.cell.2008.08.02118775299
   PubMed Web of Science ®Google Scholar
• Koppenol WH, Bounds PL, Dang CV. Otto Warburg’s contributions to current concepts of cancer metabolism. Nat Rev Cancer. 2011;11(5 ):325–337.21508971
   PubMed Web of Science ®Google Scholar
• Deantonio L, Milia ME, Cena T, et al. Anal cancer FDG-PET standard uptake value: correlation with tumor characteristics, treatment response and survival. Radiol Med. 2016;121(1 ):54–59. doi:10.1007/s11547-015-0562-926126968
   PubMed Web of Science ®Google Scholar
• Suh C, Kang YK, Roh JL, et al. Prognostic value of tumor 18F-FDG uptake in patients with untreated extranodal natural killer/T-cell lymphomas of the head and neck. J Nucl Med. 2008;49(11 ):1783–1789. doi:10.2967/jnumed.108.05335518927319
   PubMed Web of Science ®Google Scholar
• Kidd EA, Siegel BA, Dehdashti F, Grigsby PW. The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival. Cancer. 2007;110(8 ):1738–1744. doi:10.1002/cncr.2297417786947
   PubMed Web of Science ®Google Scholar
• Chihara D, Oki Y, Onoda H, et al. High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma. Int J Hematol. 2011;93(4 ):502–508. doi:10.1007/s12185-011-0822-y21512731
   PubMed Web of Science ®Google Scholar
• Borst GR, Belderbos JS, Boellaard R, et al. Standardised FDG uptake: a prognostic factor for inoperable non-small cell lung cancer. Eur J Cancer. 2005;41(11 ):1533–1541. doi:10.1016/j.ejca.2005.03.02615953716
   PubMed Web of Science ®Google Scholar
• Na F, Wang J, Li C, Deng L, Xue J, Lu Y. Primary tumor standardized uptake value measured on F18-fluorodeoxyglucose positron emission tomography is of prediction value for survival and local control in non–small-cell lung cancer receiving radiotherapy meta-analysis. J Thorac Oncol. 2014;9(6 ):834–842. doi:10.1097/JTO.000000000000018524787963
   PubMed Web of Science ®Google Scholar
• Suzuki A, Xiao L, Hayashi Y, et al. Prognostic significance of baseline positron emission tomography and importance of clinical complete response in patients with esophageal or gastroesophageal junction cancer treated with definitive chemoradiotherapy. Cancer. 2011;117(21 ):4823–4833. doi:10.1002/cncr.2612221456015
   PubMed Web of Science ®Google Scholar
• Kato H, Fukuchi M, Miyazaki T, et al. Prediction of response to definitive chemoradiotherapy in esophageal cancer using positron emission tomography. Anticancer Res. 2007;27(4C ):2727–2733.
   Web of Science ®Google Scholar
• Atsumi K, Nakamura K, Abe K, et al. Prediction of outcome with FDG-PET in definitive chemoradiotherapy for esophageal cancer. J Radiat Res. 2013;54(5 ):890–898. doi:10.1093/jrr/rrt02123520267
   PubMed Web of Science ®Google Scholar
• Elimova E, Wang X, Etchebehere E, et al. 18-fluorodeoxy-glucose positron emission computed tomography as predictive of response after chemoradiation in oesophageal cancer patients. Eur J Cancer. 2015;51(17 ):2545–2552. doi:10.1016/j.ejca.2015.07.04426321501
   PubMed Web of Science ®Google Scholar
• Hong D, Lunagomez S, Kim EE, et al. Value of baseline positron emission tomography for predicting overall survival in patient with nonmetastatic esophageal or gastroesophageal junction carcinoma. Cancer. 2005;104(8 ):1620–1626. doi:10.1002/cncr.2135616118804
   PubMed Web of Science ®Google Scholar
• Javeri H, Xiao L, Rohren E, et al. Influence of the baseline 18F-fluoro-2-deoxy-D-glucose positron emission tomography results on survival and pathologic response in patients with gastroesophageal cancer undergoing chemoradiation. Cancer. 2009;115(3 ):624–630. doi:10.1002/cncr.2405619130466
   PubMed Web of Science ®Google Scholar
• Landskron G, De la Fuente M, Thuwajit P, Thuwajit C, Hermoso MA. Chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res. 2014;2014:149185. doi:10.1155/2014/39412724901008
   PubMed Web of Science ®Google Scholar
• Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer. 2013;13(11 ):759–771. doi:10.1038/nrc361124154716
   PubMed Web of Science ®Google Scholar
• Porrata LF, Ristow K, Colgan JP, et al. Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin’s lymphoma. Haematologica. 2012;97(2 ):262–269. doi:10.3324/haematol.2011.05013821993683
   PubMed Web of Science ®Google Scholar
• Li ZM, Huang JJ, Xia Y, et al. Blood lymphocyte-to-monocyte ratio identifies high-risk patients in diffuse large B-cell lymphoma treated with R-CHOP. PLoS One. 2012;7(7 ):e41658. doi:10.1371/journal.pone.004165822911837
   PubMed Web of Science ®Google Scholar
• Lin GN, Peng JW, Liu DY, Xiao JJ, Chen YQ, Chen XQ. Increased lymphocyte to monocyte ratio is associated with better prognosis in patients with newly diagnosed metastatic nasopharyngeal carcinoma receiving chemotherapy. Tumour Biol. 2014;35(11 ):10849–10854. doi:10.1007/s13277-014-2362-625081376
   PubMedGoogle Scholar
• Hu P, Shen H, Wang G, Zhang P, Liu Q, Du J. Prognostic significance of systemic inflammation-based lymphocyte- monocyte ratio in patients with lung cancer: based on a large cohort study. PLoS One. 2014;9(9 ):e108062. doi:10.1371/journal.pone.010806225275631
   PubMedGoogle Scholar
• Ozawa T, Ishihara S, Kawai K, et al. Impact of a lymphocyte to monocyte ratio in stage IV colorectal cancer. J Surg Res. 2015;199(2 ):386–392. doi:10.1016/j.jss.2015.06.01426163330
   PubMed Web of Science ®Google Scholar
• Eo WK, Chang HJ, Kwon SH, et al. The Lymphocyte-Monocyte ratio predicts patient survival and aggressiveness of ovarian cancer. J Cancer. 2016;7(3 ):289–296. doi:10.7150/jca.1343226918042
   PubMed Web of Science ®Google Scholar
• Huang Y, Feng JF. Low preoperative lymphocyte to monocyte ratio predicts poor cancer-specific survival in patients with esophageal squamous cell carcinoma. Onco Targets Ther. 2015;8:137–145. doi:10.2147/OTT.S7379425609981
   PubMed Web of Science ®Google Scholar
• Han L-H, Jia Y-B, Song Q-X, Wang J-B, Wang -N-N, Cheng Y-F. Prognostic significance of preoperative lymphocyte-monocyte ratio in patients with resectable esophageal squamous cell carcinoma. Asian Pac J Cancer Prev. 2015;16(6 ):2245–2250. doi:10.7314/apjcp.2015.16.6.224525824745
   PubMedGoogle Scholar
• Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917 ):860–867. doi:10.1038/nature0132212490959
   PubMed Web of Science ®Google Scholar
• Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203 ):436–444. doi:10.1038/nature0720518650914
   PubMed Web of Science ®Google Scholar
• Hoffmann TK, Dworacki G, Tsukihiro T, et al. Spontaneous apoptosis of circulating t lymphocytes in patients with head and neck cancer and its clinical importance. Clin Cancer Res. 2002;8(8 ):2553–2562.12171883
   PubMed Web of Science ®Google Scholar
• Diaz-Montero CM, Finke J, Montero AJ. Myeloid-derived suppressor cells in cancer: therapeutic, predictive, and prognostic implications. Semin Oncol. 2014;41(2 ):174–184. doi:10.1053/j.seminoncol.2014.02.00324787291
   PubMed Web of Science ®Google Scholar
• Chanmee T, Ontong P, Konno K, Itano N. Tumor-associated macrophages as major players in the tumor microenvironment. Cancers (Basel). 2014;6(3 ):1670–1690. doi:10.3390/cancers603167025125485
   PubMed Web of Science ®Google Scholar
• Zhu Y, Li M, Bo C, et al. Prognostic significance of the lymphocyte-to-monocyte ratio and the tumor-infiltrating lymphocyte to tumor-associated macrophage ratio in patients with stage T3N0M0 esophageal squamous cell carcinoma. Cancer Immunol. 2016;66(3 ):343–354. doi:10.1007/s00262-016-1931-5
   Google Scholar
• Liu X, Li M, Zhao F, et al. The lymphocyte-monocyte ratio predicts tumor response and survival in patients with locally advanced esophageal cancer who received definitive chemoradiotherapy. Onco Targets Ther. 2017;10:871–877. doi:10.2147/OTT.S12491528243122
   PubMed Web of Science ®Google Scholar